ID   SU42T-4
AC   CVCL_RK79
DR   SKIP; SKIP001709
DR   Wikidata; Q54970771
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
RX   PubMed=28089908; DOI=10.1016/j.stem.2016.11.018; PMCID=PMC5508733;
RA   Chao M.P., Gentles A.J., Chatterjee S., Lan F., Reinisch A.,
RA   Corces M.R., Xavy S., Shen J.-F., Haag D., Chanda S., Sinha R.,
RA   Morganti R.M., Nishimura T., Ameen M., Wu H.-D., Wernig M., Wu J.C.,
RA   Majeti R.;
RT   "Human AML-iPSCs reacquire leukemic properties after differentiation
RT   and model clonal variation of disease.";
RL   Cell Stem Cell 20:329-344.e7(2017).
//